We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$35.2B
AUM Growth
+$788M
Cap. Flow
-$64.4M
Cap. Flow %
-0.18%
Top 10 Hldgs %
30.09%
Holding
5,577
New
1,148
Increased
1,513
Reduced
1,639
Closed
1,253

Sector Composition

Rank Sector Weight
1 Technology 1.2%
2 Consumer Discretionary 1.19%
3 Communication Services 0.68%
4 Financials 0.67%
5 Healthcare 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UXIN
4251
PUT
Uxin Ltd
UXIN
$315M
$32K ﹤0.01%
147
-264
-64% -$69.6K
RRD
4252
DELISTED
RR Donnelley & Sons Co.
RRD
$32K ﹤0.01%
+16,208
New +$53.5K
CVEO icon
4253
CALL
Civeo
CVEO
$376M
$31K ﹤0.01%
+1,508
New +$32.6K
JILL icon
4254
J. Jill
JILL
$278M
$31K ﹤0.01%
+3,150
New +$60K
SENS icon
4255
CALL
Senseonics Holdings Inc
SENS
$256M
$31K ﹤0.01%
750
-720
-49% -$30.4K
ASXC
4256
DELISTED
Asensus Surgical, Inc.
ASXC
$31K ﹤0.01%
1,740
+302
+21% +$6.61K
OSG
4257
DELISTED
Overseas Shipholding Group Inc.
OSG
$31K ﹤0.01%
+16,483
New +$30.5K
BLCM
4258
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$31K ﹤0.01%
+1,797
New +$48.6K
AVDL
4259
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$30K ﹤0.01%
+10,500
New +$18K
BGFV
4260
DELISTED
Big 5 Sporting Goods
BGFV
$30K ﹤0.01%
+15,602
New +$38.1K
CVIA
4261
PUT
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$30K ﹤0.01%
15,400
+800
+5% +$3.08K
CLDX icon
4262
Celldex Therapeutics
CLDX
$2.79B
$29K ﹤0.01%
10,852
-10,065
-48% -$34.2K
CLDX icon
4263
PUT
Celldex Therapeutics
CLDX
$2.79B
$29K ﹤0.01%
+10,700
New +$36.3K
EYPT icon
4264
CALL
EyePoint Inc
EYPT
$1B
$29K ﹤0.01%
1,770
+230
+15% +$3.87K
LYG icon
4265
CALL
Lloyds Banking Group
LYG
$87.2B
$29K ﹤0.01%
+10,100
New +$31.2K
TTOO
4266
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$29K ﹤0.01%
3
-1
-25% -$11.7K
HPR
4267
CALL
DELISTED
HighPoint Resources Corporation
HPR
$29K ﹤0.01%
+318
New +$35.4K
BGFV
4268
PUT
DELISTED
Big 5 Sporting Goods
BGFV
$28K ﹤0.01%
+14,500
New +$35.5K
ONIT
4269
Onity Group
ONIT
$341M
$28K ﹤0.01%
890
-325
-27% -$8.67K
PER
4270
CALL
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$28K ﹤0.01%
15,300
+2,400
+19% +$5.04K
ATHX
4271
DELISTED
Athersys, Inc. Common Stock
ATHX
$27K ﹤0.01%
633
+1
+0.2% +$41
EGY icon
4272
Vaalco Energy
EGY
$540M
$25K ﹤0.01%
+14,786
New +$28.9K
GSM icon
4273
PUT
FerroAtlántica
GSM
$628M
$24K ﹤0.01%
14,200
+1,200
+9% +$2.29K
TRQ
4274
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
$24K ﹤0.01%
1,970
-1,000
-34% -$13.8K
BTE icon
4275
PUT
Baytex Energy
BTE
$2.86B
$23K ﹤0.01%
14,900
+2,300
+18% +$4.17K

Similar funds

Wolverine Trading's Q2 2019 Portfolio in Review

As of Q2 2019, Wolverine Trading held 5,577 positions worth $35.2B, up 2.3% from $34.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Wolverine Trading's Q2 2019 filing shows 1,148 new, 1,513 increased, 1,639 reduced and 1,253 closed positions. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 21,298 shares worth $35.4M. The largest sale was Invesco QQQ Trust, an estimated $322M.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, up from 0.87% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Wolverine Trading's largest Q2 2019 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 21,298 shares worth $35.4M.
  • Wolverine Trading added most to Alphabet (Google) Class A in Q2 2019, an estimated $47.4M increase.
  • Wolverine Trading's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $322M.
  • Wolverine Trading fully exited Invesco DB Gold Fund in Q2 2019, selling an estimated $41.9M.
  • Wolverine Trading's ten largest holdings make up 30% of its $35.2B portfolio in Q2 2019.
  • Wolverine Trading opened 1,148 new positions and closed 1,253 in Q2 2019.
  • Wolverine Trading's portfolio value rose 2.3% quarter-over-quarter to $35.2B.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.